Astex Pharmaceuticals to Announce 2012 Third Quarter Financial Results on October 30, 2012
October 23, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif, Oct. 23, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Scientists Publish the Discovery of Novel Allosteric Modulators for the Key Therapeutic Targets HCV NS3 and PKM2 in Nature Journals
October 15, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 15, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces the Appointment of President Harren Jhoti, PhD to the BioIndustry Association Board of Directors
October 10, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Earns $5 Million for First Commercial Sale of DACOGEN(R) in the European Union
October 09, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 9, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Initiation of SGI-110 Phase 2 Trial in Platinum-Resistant Recurrent Ovarian Cancer Patients
October 02, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Present at BIO Investor Forum
October 02, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Oct. 2, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
DACOGEN(R) Approved in the European Union for the Treatment of Acute Myeloid Leukemia
September 28, 2012 06:20 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 28, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Discontinues Amuvatinib Clinical Development Program
September 21, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 21, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals to Participate on Oncology Panels at Upcoming Investor Conferences
September 18, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 18, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...
Astex Pharmaceuticals Announces Initiation of HSP90 Inhibitor AT13387 Clinical Trial in Prostate Cancer Patients
September 10, 2012 06:00 ET
|
Astex Pharmaceuticals, Inc.
DUBLIN, Calif., Sept. 10, 2012 (GLOBE NEWSWIRE) -- Astex Pharmaceuticals, Inc. (Nasdaq:ASTX), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics,...